NCT01865721

Optimizing the Use of Entonox® During Screening Colonoscopy

Optimizing the Use of Entonox® During Screening Colonoscopy: an Open Randomised Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust · Academic / Other
• Sex: All
• Age: 60 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study will randomise patients undergoing screening colonoscopy to receive Entonox either continuously or as required. Both these methods are used in the published studies of Entonox and in clinical practice. Null hypothesis There will be no difference in pain levels between these two methods of Entonox administration

Conditions

• Bowel Cancer Screening
• Analgesia
• Entonox
• Colonoscopy

Interventions

Type	Name	Description
DRUG	Entonox	Entonox will be used according to the allocated method

Timeline

• Start date: 2013-01-01
• Primary completion: 2014-04-01
• Completion: 2014-04-01
• First posted: 2013-05-31
• Last updated: 2019-09-23

Locations

1 site across 1 country: United Kingdom